BENHANAN WAYS: Open Payments
NPI 1073188967 · STORRS, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,629 in 74 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,017 · 2025 $1,629
Food & beverage: $1,540Education: $89
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $229 |
| Actelion Pharmaceuticals US, Inc. | 7 | $222 |
| BridgeBio Pharma, Inc. | 8 | $191 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $168 |
| Amgen Inc. | 9 | $143 |
| HARMONY BIOSCIENCES LLC | 4 | $115 |
| Alnylam Pharmaceuticals Inc. | 4 | $107 |
| Novo Nordisk Inc | 4 | $103 |
| GlaxoSmithKline, LLC. | 5 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
Products named: Attruby, OPSUMIT, JARDIANCE, REPATHA, ELIQUIS, WAKIX, VYNDAQEL, Wegovy.
Industry payments across CT — which companies pay providers there.
